Article info

Download PDFPDF

Original research
Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer

Authors

  1. Correspondence to Dr Kejin Wu; kejinwu1128{at}163.com; Professor Bin Li; binli{at}shsmu.edu.cn; Professor Dan Li; danli{at}shsmu.edu.cn
View Full Text

Citation

Bai F, Zhang P, Fu Y, et al
Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer

Publication history

  • Accepted February 14, 2020
  • First published April 16, 2020.
Online issue publication 
April 16, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.